Sean Smith
Career history of Sean Smith
Former positions of Sean Smith
Companies | Position | Start | End |
---|---|---|---|
APTEVO THERAPEUTICS INC. | Comptroller/Controller/Auditor | 01/04/2017 | 01/08/2019 |
NEUROGENE INC. | Comptroller/Controller/Auditor | 01/10/2019 | 31/03/2023 |
Director of Finance/CFO | 31/03/2023 | - |
Training of Sean Smith
University of Washington | Masters Business Admin |
University of North Texas | Graduate Degree |
Statistics
International
United States | 5 |
Operational
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 1 |
Graduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
APTEVO THERAPEUTICS INC. | Health Technology |
Private companies | 1 |
---|---|
Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Sean Smith
- Experience